Correlation Between Nutranomics and Canntab Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nutranomics and Canntab Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nutranomics and Canntab Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nutranomics and Canntab Therapeutics Limited, you can compare the effects of market volatilities on Nutranomics and Canntab Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nutranomics with a short position of Canntab Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nutranomics and Canntab Therapeutics.

Diversification Opportunities for Nutranomics and Canntab Therapeutics

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Nutranomics and Canntab is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Nutranomics and Canntab Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canntab Therapeutics and Nutranomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nutranomics are associated (or correlated) with Canntab Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canntab Therapeutics has no effect on the direction of Nutranomics i.e., Nutranomics and Canntab Therapeutics go up and down completely randomly.

Pair Corralation between Nutranomics and Canntab Therapeutics

If you would invest  0.01  in Canntab Therapeutics Limited on August 26, 2024 and sell it today you would earn a total of  0.00  from holding Canntab Therapeutics Limited or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Nutranomics  vs.  Canntab Therapeutics Limited

 Performance 
       Timeline  
Nutranomics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Nutranomics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Nutranomics showed solid returns over the last few months and may actually be approaching a breakup point.
Canntab Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Canntab Therapeutics Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's fundamental drivers remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Nutranomics and Canntab Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nutranomics and Canntab Therapeutics

The main advantage of trading using opposite Nutranomics and Canntab Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nutranomics position performs unexpectedly, Canntab Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canntab Therapeutics will offset losses from the drop in Canntab Therapeutics' long position.
The idea behind Nutranomics and Canntab Therapeutics Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences